Leah R. Neufeld serves as Executive at Immuneering Corp, where they oversee executive responsibilities. Since joining the company, Leah R. Neufeld has executed 7 insider transactions totaling $29.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 140,000 shares valued at $0.
Leah R. Neufeld currently holds 140,000 shares of Immuneering Corp (IMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leah R. Neufeld has been a net buyer of IMRX stock. They have purchased $29.5K and sold $0 worth of shares.
Leah R. Neufeld's most recent insider trade was on Feb 3, 2026, when they sold 140,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.15 |
| Discretionary |
| Oct 1, 2025 | IMRX | $5.1K | Purchase | 800 | $6.38 | Discretionary |
| Sep 15, 2025 | IMRX | $16.9K | Award | 11,815 | $1.43 | Discretionary |
| Jul 2, 2025 | IMRX | $2.5K | Purchase | 700 | $3.57 | Discretionary |
| Mar 20, 2024 | IMRX | $11.0K | Purchase | 3,818 | $2.88 | Discretionary |
| Mar 15, 2024 | IMRX | $10.1K | Award | 6,211 | $1.62 | Discretionary |